Until now there has been no test that could detect synacthen, which when injected simulates the body to produce extra amounts of its own corticosteroid. This is most common in sports where sports ...

Mallinckrodt plc (NYSE: MNK) revealed Monday that it submitted an Investigational New Drug (IND) application for Synacthen Depot to the U.S. Food and Drug Administration (FDA). The company indicated ...

Hormonal insufficiency of the hypothalamic–pituitary–adrenal (HPA) axis is a common complication in patients who have undergone pituitary surgery. Different procedures are used to assess HPA function ...

Mallinckrodt announced that the FDA has granted Fast Track designation to the Investigational New Drug (IND) application of Synacthen Depot (tetracosactide) for the treatment of Duchenne muscular ...

This week celebrity blogger Perez Hilton and a handful of more traditional media outlets wrote about a 2,000 percent price hike for a drug used to treat infants with a rare form of epilepsy. Critics ...